| pubmed-article:17960339 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17960339 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17960339 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:17960339 | lifeskim:mentions | umls-concept:C0220647 | lld:lifeskim |
| pubmed-article:17960339 | lifeskim:mentions | umls-concept:C0220650 | lld:lifeskim |
| pubmed-article:17960339 | lifeskim:mentions | umls-concept:C1520143 | lld:lifeskim |
| pubmed-article:17960339 | lifeskim:mentions | umls-concept:C1264633 | lld:lifeskim |
| pubmed-article:17960339 | lifeskim:mentions | umls-concept:C1552944 | lld:lifeskim |
| pubmed-article:17960339 | lifeskim:mentions | umls-concept:C1880197 | lld:lifeskim |
| pubmed-article:17960339 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:17960339 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:17960339 | pubmed:dateCreated | 2007-10-25 | lld:pubmed |
| pubmed-article:17960339 | pubmed:abstractText | Whole brain radiotherapy (WBRT) is the most common treatment for brain metastases. Survival of patients with cancer of unknown primary (CUP) presenting with brain metastases is extremely poor. A radiation program with a short overall treatment time (short-course RT) would be preferable to longer programs if it provides similar outcomes. This study compares short-course RT with 20 Gy in 5 fractions (5 x 4 Gy) given over 5 days to longer programs in CUP patients. | lld:pubmed |
| pubmed-article:17960339 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17960339 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17960339 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17960339 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17960339 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:17960339 | pubmed:issn | 0179-7158 | lld:pubmed |
| pubmed-article:17960339 | pubmed:author | pubmed-author:SchildSteven... | lld:pubmed |
| pubmed-article:17960339 | pubmed:author | pubmed-author:StalpersLukas... | lld:pubmed |
| pubmed-article:17960339 | pubmed:author | pubmed-author:DunstJuergenJ | lld:pubmed |
| pubmed-article:17960339 | pubmed:author | pubmed-author:RadesDirkD | lld:pubmed |
| pubmed-article:17960339 | pubmed:author | pubmed-author:VeningaTheoT | lld:pubmed |
| pubmed-article:17960339 | pubmed:author | pubmed-author:LohynskaRadka... | lld:pubmed |
| pubmed-article:17960339 | pubmed:author | pubmed-author:BohlenGuenthe... | lld:pubmed |
| pubmed-article:17960339 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17960339 | pubmed:volume | 183 | lld:pubmed |
| pubmed-article:17960339 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17960339 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17960339 | pubmed:pagination | 631-6 | lld:pubmed |
| pubmed-article:17960339 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:meshHeading | pubmed-meshheading:17960339... | lld:pubmed |
| pubmed-article:17960339 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17960339 | pubmed:articleTitle | Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP). | lld:pubmed |
| pubmed-article:17960339 | pubmed:affiliation | Department of Radiation Oncology, University Hospital Schleswig-Holstein, Luebeck, Germany. Rades.Dirk@gm.net | lld:pubmed |
| pubmed-article:17960339 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17960339 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17960339 | lld:pubmed |
